Expert Care, Close To Home.
APU Direct
320.259.1411
888.559.1411
Advanced Prostate Cancer
- Prospective Multi-national Observational Study to Assess Health Resource Utilization Associated with Skeletal Related Events in Patients with Bone Metastases Secondary to Breast, Prostate, or Lung Cancer, or Multiple Myeloma
- A six-month, open-labeled, fixed-dose study to evaluate the safety, tolerance, pharmacokinetics and endocrine efficacy of two doses of a medication in patients with advanced prostate cancer.
